関連する実験動画

Updated: Aug 6, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

長期のタモキシフェン療法に関連した致死性ニュートロペニア

V Miké, V E Currie, T S Gee

    Lancet (London, England)
    |August 20, 1994
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
    08:19

    Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

    Published on: July 20, 2019

    Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
    05:52

    Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

    Published on: May 12, 2023

    関連する実験動画

    Last Updated: Aug 6, 2026

    Isolation and Characterization of Neutrophils with Anti-Tumor Properties
    10:15

    Isolation and Characterization of Neutrophils with Anti-Tumor Properties

    Published on: June 19, 2015

    Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
    08:19

    Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

    Published on: July 20, 2019

    Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
    05:52

    Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

    Published on: May 12, 2023

    関連する概念動画

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ